EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Highly reliable GIGA-sized synthetic human therapeutic antibody library construction

Chao-Yang Huang, Ying-Yung Lok, Chia-Hui Lin, Szu-Liang Lai, Yen-Yu Wu, Chih-Yung Hu, Chu-Bin Liao, Chen-Hsuan Ho, Yu-Ping Chou, Yi-Hsuan Hsu, Yu-Hsun Lo, Edward Chern

Frontiers in Immunology · 2023

DOI: 10.3389/fimmu.2023.1089395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, 2023. Verfasst von Chao-Yang Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: niChe Lab for Stem Cell and Regenerative Medicine, Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Single-Chain Antibodies, Bacteriophages. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Ministry of Economic Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monoclonal antibodies (mAbs) and their derivatives are the fastest expanding category of pharmaceuticals. Efficient screening and generation of appropriate therapeutic human antibodies are important and urgent issues in the field of medicine. The successful in vitro biopanning method for antibody screening largely depends on the highly diverse, reliable and humanized CDR library. To rapidly obtain potent human antibodies, we designed and constructed a highly diverse synthetic human single-chain variable fragment (scFv) antibody library greater than a giga in size by phage display. Herein, the novel TIM-3-neutralizing antibodies with immunomodulatory functions derived from this library serve as an example to demonstrate the library’s potential for biomedical applications.

Methods

The library was designed with high stability scaffolds and six complementarity determining regions (CDRs) tailored to mimic human composition. The engineered antibody sequences were optimized for codon usage and subjected to synthesis. The six CDRs with variable length CDR-H3s were individually subjected to β-lactamase selection and then recombined for library construction. Five therapeutic target antigens were used for human antibody generation via phage library biopanning. TIM-3 antibody activity was verified by immunoactivity assays.

Results

We have designed and constructed a highly diverse synthetic human scFv library named DSyn-1 (DCB Synthetic-1) containing 2.5 × 10 10 phage clones. Three selected TIM-3-recognizing antibodies DCBT3-4, DCBT3-19, and DCBT3-22 showed significant inhibition activity by TIM-3 reporter assays at nanomolar ranges and binding affinities in sub-nanomolar ranges. Furthermore, clone DCBT3-22 was exceptionally superior with good physicochemical property and a purity of more than 98% without aggregation.

Conclusion

The promising results illustrate not only the potential of the DSyn-1 library for biomedical research applications, but also the therapeutic potential of the three novel fully human TIM-3-neutralizing antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Chain AntibodiesBacteriophagesHumansPeptide LibraryHepatitis A Virus Cellular Receptor 2Complementarity Determining RegionsAntibodies, MonoclonalAntibodies, Neutralizing

Stichwörter der Autor:innen

TIM-3antibody therapeuticsphage displaysingle-chain variable fragment (scFv)synthetic antibody library

Substanzen

Peptide LibraryHepatitis A Virus Cellular Receptor 2Complementarity Determining RegionsAntibodies, MonoclonalSingle-Chain AntibodiesAntibodies, Neutralizing

Autor:innen und Institutionen

  • niChe Lab for Stem Cell and Regenerative Medicine, Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan.
  • Development Center for Biotechnology, New Taipei City, Taiwan.
  • Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, Taiwan.

Förderung

  • National Science and Technology Council
  • Ministry of Economic Affairs

Zitieren

APA

Huang, C. Y., Lok, Y. Y., Lin, C. H., Lai, S. L., Wu, Y. Y., Hu, C. Y., Liao, C. B., Ho, C. H., Chou, Y. P., Hsu, Y. H., Lo, Y. H., & Chern, E. (2023). Highly reliable GIGA-sized synthetic human therapeutic antibody library construction. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1089395

Vancouver

Huang CY, Lok YY, Lin CH, Lai SL, Wu YY, Hu CY, et al. Highly reliable GIGA-sized synthetic human therapeutic antibody library construction. Frontiers in Immunology. 2023. doi:10.3389/fimmu.2023.1089395

BibTeX
@article{Huang2023,
  author = {Huang, Chao-Yang and Lok, Ying-Yung and Lin, Chia-Hui and Lai, Szu-Liang and Wu, Yen-Yu and Hu, Chih-Yung and Liao, Chu-Bin and Ho, Chen-Hsuan and Chou, Yu-Ping and Hsu, Yi-Hsuan and Lo, Yu-Hsun and Chern, Edward},
  title = {Highly reliable GIGA-sized synthetic human therapeutic antibody library construction},
  journal = {Frontiers in Immunology},
  year = {2023},
  doi = {10.3389/fimmu.2023.1089395}
}
Kostenlos starten →